Internal Server Error

Pharmacelera - About the company

Pharmacelera is a series A company based in Barcelona (Spain), founded in 2015 by Enric Herrero and Enric Gibert Codina. It operates as a Hardware and software solutions for computer-aided drug design. Pharmacelera has raised $7.1M in funding from HERAN Partners. The company has 184 active competitors, including 43 funded and 19 that have exited. Its top competitors include companies like Certara, Cartography Biosciences and Astex Pharmaceuticals.

Company Details

Hardware and software solutions for computer-aided drug design. Products include PharmScreen- a ligand-based virtual screening tool that uses a 3D ligand-alignment algorithm based on the interaction fields for lead generation, and PharmQSAR- a 3D Quantitative Structure-Activity Relationship (QSAR) tool able to combine multiple fields of interaction.
Social
X
Email ID
*****@pharmacelera.com
Key Metrics
Founded Year
2015
Location
Barcelona, Spain
Stage
Series A
Total Funding
$7.1M in 6 rounds
Latest Funding Round
Ranked
Employee Count
28 as on Jul 31, 2026
Similar Companies
Sign up to download Pharmacelera's company profile

Pharmacelera's funding and investors

Pharmacelera has raised a total funding of $7.1M over 6 rounds. Its first funding round was on Jun 01, 2018. Its latest funding round was a Series A round on Feb 18, 2026 for $*****. 4 investors participated in its latest round. Pharmacelera has 8 institutional investors.

Here is the list of recent funding rounds of Pharmacelera:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 18, 2026
9202354
Series A
9370115
9639127
3399082
3361447
Aug 31, 2022
6989207
Grant (prize money)
5685133
8536781
6034947
Sep 01, 2020
9484838
Grant (prize money)
8663246
6524924
4416569
lockAccess funding benchmarks and valuations. Sign up today!

Pharmacelera's founders and board of directors

Founder? Claim Profile
The founders of Pharmacelera are Enric Herrero and Enric Gibert Codina. Enric Gibert Codina is the CEO of Pharmacelera.
Here are the details of Pharmacelera's key team members:

Pharmacelera's employee count trend

Pharmacelera has 28 employees as of Jul 26. Here is Pharmacelera's employee count trend over the years:
Employee count trend for Pharmacelera
lockUncover Pharmacelera's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Pharmacelera's Competitors and alternates

Top competitors of Pharmacelera include Certara, Cartography Biosciences and Astex Pharmaceuticals. Here is the list of Top 10 competitors of Pharmacelera, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Certara
Certara
2008, Princeton (United States), Public
Provider of a platform for in silico drug discovery and consulting services
-
65/100
2nd
Logo for Cartography Biosciences
Cartography Biosciences
2020, Foster City (United States), Series B
Provider of a platform to discover immunotherapeutics
$124M
63/100
3rd
Logo for Astex Pharmaceuticals
Astex Pharmaceuticals
1991, Pleasanton (United States), Acquired
Oncology and CNS drug discovery and development using cutting-edge technology
$3M
60/100
4th
Logo for Pharmacelera
Pharmacelera
2015, Barcelona (Spain), Series A
Hardware and software solutions for computer-aided drug design
$7.1M
59/100
5th
Logo for TOLREMO therapeutics
TOLREMO therapeutics
2017, Zurich (Switzerland), Series A
Developing anti-cancer small molecules targeting novel drug resistance pathways
$55.8M
59/100
6th
Logo for Oxford Drug Design
Oxford Drug Design
2001, Oxford (United Kingdom), Series A
Provider of computer-aided design of antibiotics for MDR infections
$12.4M
59/100
7th
Logo for Inpharmatica
Inpharmatica
1998, London (United Kingdom), Acquired
Developer of predictive informatics based platform for drug discovery
$75M
58/100
8th
Logo for Genialis
Genialis
2015, Boston (United States), Series A
Developer of end-to-end bioinformatics software solutions
$16M
56/100
9th
Logo for CytoReason
CytoReason
2016, Haifa (Israel), Series C
Discovering immune system based drugs by biological data analytics
$130M
55/100
10th
Logo for Probius
Probius
2016, Fremont (United States), Seed
Digital biochemical analysis tool for healthcare researchers
$2.44M
53/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Pharmacelera's competitors? Click here to see the top ones

Pharmacelera's Investments and acquisitions

Pharmacelera has made no investments or acquisitions yet.

Reports related to Pharmacelera

Here is the latest report on Pharmacelera's sector:

News related to Pharmacelera

Media has covered Pharmacelera for a total of 2 events in the last 1 year.
•
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Pharmacelera

Explore our recently published companies
  • Haile Construction - United States based, 2013 founded, Unfunded company
  • ING-GRAD - Croatia based, 1985 founded, Unfunded company
  • Metro - St. Gallen based, 2002 founded, Public company
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford